Exicure (XCUR) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2026)
Exicure (XCUR) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
41.33% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
25.45% |
| Date | Value |
|---|
| Mar 31, 2026 |
25.45% |
| Dec 31, 2025 |
-28.31% |
| Sep 30, 2025 |
27.89% |
| Jun 30, 2025 |
37.26% |
| Mar 31, 2025 |
30.78% |
| Dec 31, 2024 |
9.41% |
| Sep 30, 2024 |
58.56% |
| Jun 30, 2024 |
58.40% |
| Mar 31, 2024 |
-50.79% |
| Dec 31, 2023 |
-67.68% |
| Sep 30, 2023 |
-212.10% |
| Jun 30, 2023 |
-138.70% |
| Mar 31, 2023 |
-316.02% |
| Mar 31, 2022 |
-158.38% |
